Follistatin serum levels in women with preeclampsia are significantly reduced at the late second and third trimesters (25+0–40+0 weeks of gestation), though changes in maternal serum follistatin-like 3 remain uncertain. The gene discussed is FSTL3; the disease is preeclampsia.